Navigation Links
Even Mild Infections Hasten Decline With Alzheimer's
Date:9/7/2009

They speed memory loss as much as 10-fold, researchers find,,

MONDAY, Sept. 7 (HealthDay News) -- For people with Alzheimer's disease, even a minor infection can double the rate of memory loss, British researchers report.

In this new study, researchers found that Alzheimer's patients who had respiratory, gastrointestinal or other infections -- even minor bumps and bruises -- can have high levels of tumor necrosis factor-alpha (TNF-a), in their blood. TNF-a is a protein linked to inflammation, and has been associated with memory loss or other types of cognitive decline.

"Illnesses that we normally consider to be of little consequence in the healthy aged person need to be taken more seriously in patients with Alzheimer's disease," said lead researcher Clive Holmes, from the Clinical Neurosciences Research Division at the University of Southampton in the U.K.

"Short-lived illnesses or conditions that cause inflammation outside the brain are associated with a marked decline in memory function in patients that have Alzheimer's disease. This decline is not a temporary effect, and remains after the illness has resolved," he added.

The report is published in the Sept. 8 issue of Neurology.

For the study, Holmes and colleagues looked at blood tests and cognitive ability in 222 Alzheimer's patients. The researchers measured these factors at the start of the study and three more times during the trial.

In addition, caregivers reported any infections or accidental injuries suffered by the patients during that time.

Over the six months of the study, 110 people had an infection or injury that resulted in inflammation. These people had memory loss at twice the rate of those who did not have infections or injuries, the researchers found.

Memory loss among patients with high TNF-a levels at the start of the study was four times greater than among patients with low TNF-a levels.

"The effect of these illnesses on memory function is most marked in subjects who also have existing chronic inflammatory conditions," Holmes said. "Here, the rate of memory decline is 10-fold. We believe the signal is coming from these illnesses and being sent to the brain by TNF-a, a protein known to be associated with a range of inflammatory conditions," he said.

For those whose TNF-a levels were high at the start of the study, an infection increased their memory loss 10 times over those who had low TNF-a levels, the study authors found.

Greater care is needed to prevent these conditions occurring in people with Alzheimer's disease, Holmes said.

"Thus the use of influenza vaccinations should be encouraged, and early treatment of infections may reduce the deleterious effect of these infections," he said.

"Finally, the development of drugs or lifestyle changes, such as moderate exercise that has been shown to reduce TNF-a in patients with Alzheimer's disease, are worth examining for their beneficial effects on slowing down the disease process," Holmes said.

Greg M. Cole, associate director of the Alzheimer's Disease Research Center at UCLA David Geffen School of Medicine, said this is a very interesting study associating episodes of infectious disease with increases in a pro-inflammatory molecule in blood and rates of cognitive decline in people who already have Alzheimer's disease.

"Like all association studies, it does not prove causal relationships," Cole said. "However, it makes some sense because the molecule they measure in blood, TNF-a, is known to traffic from the blood to trigger increased brain inflammation in animal models, and has been a candidate target for disease intervention," he said.

However, common anti-inflammatory medications, such as Celebrex or Aleve, have generally failed to slow disease progression in clinical trials, Cole said.

"This study raises the question of whether or not anti-inflammatory drugs in previous and perhaps future trials may have been or may be more helpful in the subset of dementia patients with other conditions causing inflammation outside the brain," he said. "If this is true, it might help explain why people taking anti-inflammatory drugs for systemic inflammatory diseases appear to have less risk for getting Alzheimer's."

Maria Carrillo, director of medical and scientific relations at the Alzheimer's Association, noted that TNF-a is not the only protein involved in inflammation and cognition.

"This study tells us that inflammatory processes are involved in cognition," Carrillo said. "TNF-a could be a therapeutic target, but there are other neuromodulators out there that are therapeutic targets," she said.

More information

For more information on Alzheimer's disease, visit the Alzheimer's Association.



SOURCES: Clive Holmes, MRCPsych, Ph.D., Clinical Neurosciences Research Division, University of Southampton, U.K.; Greg M. Cole, Ph.D., neuroscientist, Greater Los Angeles VA Healthcare System, and associate director, Alzheimer's Disease Research Center, UCLA David Geffen School of Medicine; Maria Carrillo, Ph.D., director, medical and scientific relations, Alzheimer's Association; Sept. 8, 2009, Neurology


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hospital infections cost $1 billion in lost bed days
2. Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting
3. Antibiotics Being Prescribed Less for Respiratory Infections
4. MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes
5. Rapid Swine Flu Test Misses Many Infections
6. Eliminating Cell Receptor Prevents Infections in Animal Study
7. Pet Bite Injuries: K-State Veterinarian Shares Tips to Minimize Risk of Bites and Bite-Related Infections
8. Following CMS Cuts to Reimbursement for Medical Errors, New Devices Aimed at Reducing Nosocomial Infections Emerge
9. Immune System Gene Discovery Sheds Light on Staph Infections
10. Orlando Regional Medical Center (ORMC) Implements PNA FISH(R) Tests to Help Provide Better Care for Patients with Bloodstream Infections
11. Breast cancer drug shows promise against serious infections
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Even Mild Infections Hasten Decline With Alzheimer's
(Date:5/26/2016)... ... 26, 2016 , ... The MIAMI Institute for Age Management and Intervention celebrates ... MD, ABAARM. Dr. Adonis , Wellness Physician of the MIAMI Institute is certified ... Institute for Functional Medicine. , He also heads up FITTLab, the comprehensive medical testing ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading ... PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power ... the 8 hour interactive course to qualify participants as certified PowerWave trainers. ...
(Date:5/26/2016)... ... 2016 , ... OncLive® , a leading digital provider ... University of Virginia (UVA) Cancer Center to its quickly expanding Strategic ... will publicize and promote public awareness of UVA Cancer Center’s latest advances in ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... A ... Valley-based startup, The Dough Bar, has ignited an undeniable buzz in the ... a doughnut. But not just any doughnut.  These doughnuts are packed with 11 grams ...
(Date:5/26/2016)... ... 2016 , ... Workrite Ergonomics announced today that Phil Cloutier ... their rapidly expanding portfolio of customer and end user accounts. , ... an M.B.A. with concentration in management from Bryant University in Smithfield, Rhode Island. ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... 24, 2016 Los innovadores ... del mundo, introduce catéteres para la intervención de ... una compañía global especializada en el suministro de ... su cartera incluyendo productos para tratar la enfermedad ... PTA son los dispositivos de primera entrada de ...
Breaking Medicine Technology: